The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach
Journal of Gastrointestinal Cancer · 2024
DOI: 10.1007/s12029-024-01022-w ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Gastrointestinal Cancer, 2024. Verfasst von Mahdieh Razmi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran. razmi_mahdyeh@yahoo.com. Hauptthemen laut MEDLINE: Ki-67 Antigen, Gastrointestinal Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 104 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: This study aimed to determine if Ki-67, a commonly used marker to measure tumor proliferation, is a reliable prognostic factor in various types of gastrointestinal (GI) cancers based on current high-quality multivariable evidence. METHODS: A comprehensive search was conducted in PubMed, Embase, Scopus, and ISI Web of Science databases to investigate the association between Ki-67 positivity and overall survival (OS) and disease/recurrence-free survival (DFS/RFS) in GI cancers. Heterogeneity was assessed using Chi-square-based Q and I2 analyses and publication bias using funnel plots and Egger's analysis. In addition, Ki-67 levels in different GI cancers were examined by different platforms. The prognostic capability of Ki-67, gene ontology (GO), and pathway enrichment analysis were obtained from GEPIA2 and STRING. RESULTS: Totally, 61 studies, involving 13,034 patients, were deemed eligible for our evaluation. The combined hazard ratios (HRs) demonstrated the prediction ability of overexpressed Ki-67 for a worse OS (HR: 1.67, P < 0.001; HR: 1.37, P = 0.021) and DFS/RFS (HR: 2.06, P < 0.001) in hepatocellular and pancreatic malignancies, respectively, as confirmed by multi-omics databases. However, similar correlation was not found in esophageal, gastric, and colorectal cancers. Furthermore, most of the associations were identified to be robust based on different subcategories and publication bias assessment. Finally, enriched Ki-67-related genes were found to be involved in various important signaling pathways, such as cell cycle, P53 signaling network, and DNA damage responses. CONCLUSION: This study supports that Ki-67 can serve as an independent prognostic biomarker for pancreatic and hepatocellular malignancies in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran. razmi_mahdyeh@yahoo.com.
- Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Surgery, University of California, Irvine, CA, USA.
- Department of Tissue Engineering and Regenerative Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
- Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Zitieren
APA
Razmi, M., Tajik, F., Hashemi, F., Yazdanpanah, A., Hashemi-Niasari, F., & Divsalar, A. (2024). The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-024-01022-w
Vancouver
Razmi M, Tajik F, Hashemi F, Yazdanpanah A, Hashemi-Niasari F, Divsalar A. The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach. Journal of Gastrointestinal Cancer. 2024. doi:10.1007/s12029-024-01022-w
BibTeX
@article{Razmi2024,
author = {Razmi, Mahdieh and Tajik, Fatemeh and Hashemi, Farideh and Yazdanpanah, Ayna and Hashemi-Niasari, Fatemeh and Divsalar, Adeleh},
title = {The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach},
journal = {Journal of Gastrointestinal Cancer},
year = {2024},
doi = {10.1007/s12029-024-01022-w}
}
EUVIMED